Nevro Corp.

NYSE NVRO

Nevro Corp. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2024: USD 49.96 M

Nevro Corp. Net Cash Used Provided By Financing Activities is USD 49.96 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 2,160.45% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Nevro Corp. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 2.21 M, a 498.20% change year over year.
  • Nevro Corp. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -555.00 K, a 99.67% change year over year.
  • Nevro Corp. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -167.52 M, a -146.13% change year over year.
  • Nevro Corp. Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 363.15 M, a 2,925.54% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
NYSE: NVRO

Nevro Corp.

CEO Mr. Kevin R. Thornal
IPO Date Nov. 6, 2014
Location United States
Headquarters 1800 Bridge Parkway
Employees 1,215
Sector Health Care
Industries
Description

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Similar companies

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

CVRX

CVRx, Inc.

USD 16.15

7.38%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

IRMD

IRadimed Corporation

USD 57.52

1.79%

ELMD

Electromed, Inc.

USD 31.05

1.90%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email